USA orders are completed as needed when severe cases present, 'Just-in-time' delivery style...So, still very early days in the US for BTM.
I'm glad as well the DFU study is now similarly focused on the serious use case scenarios - I.e. limb salvage.
Much like the 'sustainability' focus in India that Swami talks about. Meeting the highest need patient scenarios may not have the highest TAM (in theory). But the stakeholder engagement & market penetration = long term growth & profit....
I'm punting on a T/O offer at around $200M rev. (run rate) in 18 months time... by this time the above & more will be maturing nicely. Target $5-6 with a lot of volatility along the way.
PNV - Banter and General Comments, page-11632
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.20 |
Change
0.050(2.33%) |
Mkt cap ! $1.518B | |||
| Open | High | Low | Value | Volume |
| $2.15 | $2.20 | $2.14 | $3.020M | 1.387M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 450 | $2.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.20 | 24206 | 7 |
View Market Depth
| Last trade - 16.10pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.20 |
Change
0.050 ( 2.13 %) |
||||
| Open | High | Low | Volume | ||
| $2.15 | $2.20 | $2.14 | 347849 | ||
| Last updated 15.59pm 30/05/2024 ? | |||||
| PNV (ASX) Chart |